The malaria-high blood pressure hypothesis by Etyang, Anthony O. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1161/CIRCRESAHA.116.308763
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Etyang, A. O., Smeeth, L., Cruickshank, J. K., & Scott, J. A. G. (2016). The malaria-high blood pressure
hypothesis. Circulation Research, 119(1), 36-40. 10.1161/CIRCRESAHA.116.308763
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
36
Age standardized mean blood pressures (BPs) are higher in many parts of Asia and sub-Saharan Africa than in high-
income countries.1 Despite the high burden of cardiovascular 
disease in low- and middle-income countries (LMIC), few 
studies have examined their pathophysiology or treatment.2,3 
Although demographic and lifestyle changes including urban-
ization4 contribute substantially to the burden of hypertension 
in LMICs, examining factors unique to or more prevalent in 
LMIC settings might reveal new pathophysiological mecha-
nisms that could aid efforts to control the condition.
Editorial, see p 7 
In This Issue, see p 2
The rise of cardiovascular disease in LMIC is occurring against 
the background of continuing high burden of infectious diseases.5,6 
Several studies in more developed settings have reported links be-
tween infectious or inflammatory conditions and cardiovascular 
disease. In this article, we outline the hypothesis that hypertension, 
the leading risk factor for death in LMIC,7 could be linked to one 
of the leading infectious conditions in the same region, malaria.
The Malaria–Hypertension Hypothesis
We postulate that malaria contributes to the burden of hyper-
tension in LMIC in the following ways:
1. Malaria in pregnancy leads to low birth weight through 
pathophysiologically connected mechanisms.8 In areas with 
high malaria endemicity where women are likely to have ac-
quired immunity to prevent most febrile episodes, low birth 
weight results from fetal growth restriction, which is a conse-
quence of impaired uteroplacental blood flow9 and maternal 
anemia (which is itself because of malaria).10,11 Febrile malaria 
episodes that are more likely among women with low immu-
nity are thought to induce uterine contractions, which are me-
diated by elevated levels of tumor necrosis factor-α leading to 
preterm birth.12,13 Malaria is also associated with hypertensive 
disorders of pregnancy such as gestational hypertension and 
preeclampsia in young primigravid women,14–16 and these are 
risk factors for low birth weight.17 Low birth weight children 
have an increased incidence of hypertension in later life.18–21 In 
a study conducted in Ibadan, Nigeria, infants of mothers who 
experienced malaria during pregnancy had a higher increase 
in BP levels during the first year of life compared with those 
who did not.22 Because BP levels track strongly through to 
adulthood, such differences could significantly influence the 
prevalence of adult hypertension.23–25 By virtue of its associa-
tion with hypertensive disorders of pregnancy that are them-
selves risk factors for essential hypertension in women,26,27 
malaria likely contributes to an intergenerational vicious cycle 
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of disease susceptibility because hypertensive parents bear 
children who develop hypertension more frequently.28,29
2. Malaria is associated with stunting and malnutrition in 
childhood,30,31 which predisposes to the development of hyper-
tension in later life.19,23,32
Although the biological pathways have not been fully charac-
terized, postulated mechanisms involved in the development of hy-
pertension after stunting and chronic malnutrition include reduced 
nephron numbers18 and premature senescence in the kidney, which 
is particularly prominent when there is rapid weight gain after 
growth restriction.33 In addition, Jamaican survivors of severe acute 
malnutrition in childhood were found at the age of 30 years to have 
markedly smaller left ventricular outflow tracts with reduced car-
diac output in the presence of elevated peripheral resistance, a pat-
tern of changes that is likely to lead to hypertension in later life.34
3. Malaria is a cause of chronic inflammation,35 and inflam-
mation predisposes to cardiovascular diseases in high-income 
countries.36 In a prospective study of 20 525 female US health 
professionals, there was a linear relationship between baseline 
C-reactive protein levels and incident hypertension.37 Patients 
with inflammatory bowel disease and rheumatoid arthritis have 
increased arterial stiffness, which precedes hypertension.38–40 
The link between inflammatory conditions and hypertension 
may be related to perturbations in the levels of endothelial-based 
growth factors. Angiopoietin-2 (Ang-2) is a multimeric ligand 
of the Tie 2 receptor, part of a vascular-specific tyrosine kinase 
signaling pathway that is essential for vessel development and 
stability.41 Ang-2 is predominantly secreted by endothelial cells 
and some smooth muscle cells in many inflammatory and an-
giogenic states (Figure). Ang-2 levels are elevated in children 
with severe malaria in several different settings35,42–45 and in 
returning travellers infected with malaria.46 Ang-2 levels pre-
dict cardiovascular disease in children with chronic kidney 
disease.47 Although no causal association has been established, 
several studies have demonstrated an association between Ang-
2 levels and arterial stiffness and BP in adults.48,49
Testing the Hypothesis
Observational Studies
Ecological studies examining BP levels in relation to malaria 
incidence are hampered by the lack of finely scaled data on the 
relevant BP distributions. A worldwide study on BP levels had 
scarce raw data on BP from sub-Saharan Africa, where most 
malaria endemic countries are situated.1 In contrast, there are 
good epidemiological data on the spatial and temporal distri-
bution of malaria.50
Although traditional case–control studies (with malaria as 
the exposure and hypertension as the outcome) could provide 
an efficient way to test the hypothesis, they are limited by the 
nonspecificity and nondurability of immunologic markers for 
malaria, a prerequisite for identifying individuals who have 
previously been exposed to malaria.51–53 This limitation also 
applies to the potential use of propensity scores54 to assemble 
groups that are comparable in their risk of malaria; in order to 
generate such scores reliable immunologic markers of malaria 
exposure would be needed.
A life-course epidemiological approach with longitudi-
nal cohorts from the antenatal period or birth would allow 
the study of many of the postulated pathways through which 
malaria could be leading to hypertension in LMIC. Studies 
of pregnant women and children exposed to malaria in demo-
graphic surveillance systems with good quality ascertainment 
of exposure status are necessary. However, most demographic 
surveillance systems in LMIC were only set up in the last 15 
years, and therefore may not have accumulated enough follow-
up time to examine these outcomes, assuming that the biases 
of such retrospective studies can be overcome. Prospective 
surveillance, however, would also require long follow-up and 
be expensive to conduct.
Randomized Intervention Studies
Because malaria is of such great public interest, there have been 
and will continue to be a succession of randomized controlled 
trials of interventions tested at population level, such as vac-
cines, bed nets, and drug treatments. For those interventions 
that turn out to be effective it might be possible to examine their 
effect on arterial stiffness and BP. Prospective studies of inter-
ventions known to be effective as well as studies of controlled 
human malaria infection55 cannot be used here because although 
they satisfy the criterion of having 2 randomized groups with 
and without malaria, the fact that the vascular outcomes being 
tested are potentially irreversible pose an ethical challenge.56 As 
with observational studies, extended follow-up might be needed 
as vascular differences in trial groups because of the effects of 
malaria may take longer to be apparent compared with the anti-
malarial effects of the interventions.
Animal studies are hampered by the fact that murine mod-
els of malaria and hypertension are imperfect approximations 
of their human analogs that have complex pathophysiology.57,58
Genetic Studies
Mendelian randomization studies, where genetic polymor-
phisms are used as instrumental variables representing ma-
laria exposure, would be particularly attractive for answering 
the question as they overcome many of the limitations of ob-
servational and intervention studies described above.59 Several 
hemoglobin polymorphisms provide some level of protection 
against malaria, including Hemoglobin C and S, and thalas-
semia.60–62 A comparison of arterial stiffness indices and BP 
in subjects with and without the polymorphisms in regions 
where they have been exposed to malaria in childhood would 
provide a robust test of the effect of malaria exposure on the 
development of hypertension.
An important prerequisite for using Mendelian random-
ization to make causal inferences about the effects of envi-
ronmental exposures, is that the polymorphisms should not 
display pleiotropic effects, that is, they should not influence 
the outcome being studied through a pathway that is indepen-
dent of the environmental exposure that they are being used as 
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a proxy for.59 Some studies suggest that individuals with the 
sickle cell trait (SCT) are more likely to have cardiovascular 
events especially under extreme conditions, such as military 
training or athletics.63,64 A recent study among blacks found 
similar baseline BP in those with and without SCT, although 
on follow-up there was an increased incidence of chronic kid-
ney disease in individuals with SCT.65 To exclude the possi-
bility of confounding by pleiotropy, it may be necessary to 
include a control group that has not been exposed to malaria 
or use additional independent genetic polymorphisms, such as 
α thalassemia. If malaria causes hypertension and there are no 
pleiotropic effects of SCT, then one would expect to find high-
er BP in individuals without SCT compared with those with 
SCT in groups that have been exposed to malaria. Conversely, 
there would be no difference in BP based on trait status among 
those who have not been exposed to malaria.
Implications of the Hypothesis
Current efforts at understanding hypertension in LMIC 
have had a narrow focus anchored on traditional risk fac-
tors identified among populations in high-income countries. 
Confirmation of the causative role of malaria in elevating BP 
would be of immense scientific interest and could lead to a 
paradigm shift on how to control hypertension in LMIC.
Malaria is only one of many infectious diseases that have 
a high incidence across LMICs. The inflammatory pathways 
activated in malaria infection are similar to those of other ill-
nesses.66 It is therefore likely that if malaria contributes to the 
burden of hypertension through inflammation, the same could 
be true of other chronic infections, such as HIV and tuber-
culosis, providing a novel impetus for the study and control 
of these infections. Currently, most treatment for infectious 
illnesses is focused on eliminating the pathogen with little 
regard for modulating the inflammatory responses that might 
result in adverse vascular consequences later. Elucidating 
these inflammatory pathways and their consequences would 
pave the way for trials of adjunctive therapy such as statins 
or specific cytokine antagonists to prevent adverse vascular 
remodeling as a result of infection.
Sources of Funding
A.O. Etyang, L. Smeeth, and J.A.G. Scott are funded by the Wellcome 
Trust (Fellowship numbers: 103951/Z/14/Z, 098532 and 098504). 
The Funders played no role in the preparation of this article.
Figure.  The malaria-high blood pressure hypothesis. Malaria is known to cause low birth weight, inflammation as well as stunting. All 
these factors have been separately associated with the development of high blood pressure in high-income countries. Studies are needed 
to confirm whether malaria contributes to the development of high blood pressure in low- and middle-income countries.
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What Is Known?
•	 Malaria and high blood pressure are widespread in low- and middle-
income countries.
•	 Malaria is known to cause low birth weight, stunting, and inflammation.
•	 Low birth weight, stunting, and inflammation are associated with the 
development of arterial stiffness and high blood pressure in developed 
countries.
What New Information Does This Article Contribute?
•	 We outline the likely pathophysiological mechanisms of the hypoth-
esized association between malaria and high blood pressure in low- 
and middle-income countries.
•	 This hypothesis can be tested through well-designed ecological and 
cohort studies or using Mendelian randomization techniques.
Despite the knowledge that malaria causes low birth weight, 
inflammation, and stunting, all of which have been associated 
with the development of hypertension, no attempt has been made 
to link the 2 conditions. In this article, we review the literature 
in support of the hypothesis that malaria could be contributing 
to the widespread problem of hypertension in low- and middle-
income countries. We also outline several ways in which this hy-
pothesis could be proven or refuted. If proven, this link would 
be a paradigm shift in efforts to prevent and control high blood 
pressure in low- and middle-income countries.
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